Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reliance Life Sciences

www.rellife.com

Latest From Reliance Life Sciences

Waverley Expands UK Cancer Portfolio

Having made its entry into the UK oncology generics market late last year with capecitabine and temozolomide, Canada’s Waverley Pharma now has clearance to add erlotinib tablets to its portfolio.

Cancer United Kingdom

Can Dr Reddy’s Carve Into Crowded Indian Avastin Biosimilar Market?

Dr Reddy’s debuts biosimilar bevacizumab in India but can the significant price differential for one strength of the product help it gnaw into a competitive market?

Commercial Strategy

Can Dr Reddy’s Carve Into Crowded Indian Avastin Biosimilar Market?

Dr Reddy’s debuts biosimilar bevacizumab in India but can the significant price differential for one strength of the product help it gnaw into a competitive market?

Commercial Strategy

India’s Intas Launches Trastuzumab At A 65% Discount

India’s Intas Pharmaceuticals will undercut domestic rivals by marketing its new biosimilar trastuzumab at a price 65% cheaper than the current market cost.

Launches Biosimilars
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Reliance Life Sciences
  • Senior Management
  • Contact Info
  • Reliance Life Sciences
    Phone: (22) 6767 8000
    Thane-Belapur Rd.
    Mumbai, 400 701
    India
UsernamePublicRestriction

Register